ArticleJournal of the International AIDS Society2018

The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.

Amy Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.